Page last updated: 2024-09-04

vatalanib and gadolinium

vatalanib has been researched along with gadolinium in 1 studies

Compound Research Comparison

Studies (vatalanib)	Trials (vatalanib)	Recent Studies (post-2010) (vatalanib)	Studies (gadolinium)	Trials (gadolinium)	Recent Studies (post-2010) (gadolinium)
276	42	98	13,838	519	6,282

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drevs, J; Dugan, M; Laurent, D; Morgan, B; Steward, WP; Thomas, AL; Unger, C; Vanhoefer, U; Wiedenmann, B	1

Reviews

1 review(s) available for vatalanib and gadolinium

Article	Year
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584. Seminars in oncology, 2003, Volume: 30, Issue:3 Suppl 6 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Contrast Media; Drug Screening Assays, Antitumor; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Phthalazines; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2003

Article

Year

Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.

Seminars in oncology, 2003, Volume: 30, Issue:3 Suppl 6

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Contrast Media; Drug Screening Assays, Antitumor; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Phthalazines; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2003